Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 0.7650
-0.0100 (-1.29%)
May 29, 2026, 4:10 PM AEST
Orthocell Market Cap
Orthocell has a market cap or net worth of 208.27 million as of May 29, 2026. Its market cap has decreased by -32.49% in one year.
Market Cap
208.27M
Enterprise Value
164.42M
Revenue
9.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.77
Market Cap Chart
Since August 12, 2014, Orthocell's market cap has increased from 29.70M to 208.27M, an increase of 601.26%. That is a compound annual growth rate of 17.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 208.27M | -29.25% |
| Dec 31, 2025 | 294.37M | -9.37% |
| Dec 31, 2024 | 324.80M | 297.55% |
| Dec 29, 2023 | 81.70M | 1.05% |
| Dec 30, 2022 | 80.85M | -19.58% |
| Dec 31, 2021 | 100.54M | 20.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 503.29M |
| Clinuvel Pharmaceuticals | 451.83M |
| Tetratherix | 345.71M |
| Starpharma Holdings | 284.28M |
| Recce Pharmaceuticals | 161.94M |
| Actinogen Medical | 143.65M |
| Nyrada | 126.15M |
| Island Pharmaceuticals | 115.41M |